Diabetes Drug Injury Lawyers
Prescription medications designed to treat Type 2 diabetes work by stimulating the release of certain chemicals in the brain, pancreas, and bloodstream to improve blood glucose levels in the body. These diabetes drug medications also reduce insulin resistance in the liver. Scientific studies have linked several Type 2 diabetes drugs to serious side effects, such as heart attacks, certain types of cancers, acute pancreatitis, and more.
At Ferrer, Poirot & Wansbrough, we’re dedicated to helping the victims of prescription drugs get compensation for their medical bills, lost wages, and pain and suffering. If you or someone you love was injured by a Type 2 diabetes drug, our experienced diabetes drug injury lawyers want to help. Call us at (800) 210-8503 or fill out a free initial consultation form.
Diabetes Drug Warnings
The U.S. Food and Drug Administration (FDA) released warnings for several Type 2 diabetes drugs, including:
The FDA released a warning stating that using Actos for more than one year may increase the risk of developing bladder cancer.
- Invokana® and Invokamet®
Patients who take the Type 2 diabetes drugs Invokana® and Invokamet® may face an increased risk of severe complications, including ketoacidosis (high levels of acid in the blood) and amputation of the leg and foot.
An FDA advisory committee concluded that taking the prescription Type 2 diabetes drug Onglyza® (saxagliptin) can increase the risk of heart failure—a fatal condition.
These medications can cause serious health complications that may leave you in the hospital, out of work, and facing expensive medical bills. Ferrer, Poirot & Wansbrough can help you get the money you deserve for your or your loved one’s drug injuries. We have the experience to build a strong case for you—call today.
Actos® is a registered trademark of Takeda Pharmaceutical Company Limited. Invokana® and Invokamet® are registered trademarks of Janssen Pharmaceuticals, Inc. Onglyza® is a registered trademark of AstraZeneca PLC.
This law firm is not associated with, sponsored by, or affiliated with the U.S. Food and Drug Administration, Takeda Pharmaceutical Company, Janssen Pharmaceticals, Inc., or AstraZeneca PLC.